Core Viewpoint - The major shareholder of Shanghai Aohua Endoscopy Co., Ltd. has completed a share reduction plan, selling a total of 1,252,840 shares, which accounts for 0.93% of the company's total shares, primarily to meet personal funding needs [1][2][3] Group 1: Shareholder Information - Before the reduction, major shareholders Gu Kang, Gu Xiaozhou, and their controlled entity, Shanghai Xiaozhou Optoelectronics Technology Co., Ltd., held a total of 41,822,800 shares, representing 31.06% of the company's total equity [1][2] - Among these, Xiaozhou Optoelectronics held 12.59% and Gu Xiaozhou held 16.14% of the total shares [1] Group 2: Reduction Plan Implementation - The reduction plan was disclosed on May 23, 2025, with a maximum reduction of 1,252,840 shares planned to be executed within three months following the disclosure [1][2] - As of June 23, 2025, the reduction was completed, with the shares sold through centralized bidding [2][3] Group 3: Financial Details of the Reduction - The shares were sold at a price range of 45.70 to 51.90 yuan per share, resulting in a total amount of approximately 60,201,714.48 yuan [3] - After the reduction, the current shareholding of the major shareholders is 40,569,960 shares, which is 30.13% of the total shares [3]
澳华内镜: 持股5%以上股东减持股份结果公告